Back to search

Article

Tumor mutational burden shapes success and resistance in cancer immunotherapy

2025-08-12

Abstract excerpt

Immunotherapy, particularly immune checkpoint blockade, has transformed cancer treatment, yet durable responses remain limited to a subset of patients and cancer types. Many tumors exhibit innate resistance or acquire resistance through immune evasion or neoantigen editing. A central factor in shaping these outcomes is the tumor mutational burden. However, cancer mutations can enhance or impair both cellular repli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1cdb77e6-9927-5b31-b098-565a2ca93439
DOI
10.1101/2025.08.09.669487
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tumor mutational burden shapes success and resistance in cancer immunotherapyDOI 10.1101/2025.08.09.669487
Select a neighboring publication to make it the new centre.